Skip to main content
. 2020 Apr 11;25(8):1766. doi: 10.3390/molecules25081766
AOD approved oncology drugs
CAS Chemical Abstracts Service registry number
CNS central nervous system
DTP Developmental Therapeutics Program
GI50 half maximal growth inhibition
IC50 half maximal inhibitory concentration
InChI IUPAC International Chemical Identifier
IQR interquartile range
LC50 half maximal lethal concentration
NCI National Cancer Institute
NSC Cancer Chemotherapy National Service Center number
NSCLC non-small cell lung cancer
PKI Protein Kinase Inhibitor
ROC receiver operating characteristic
TGI total growth inhibition